SB-277011-A dihydrochloride，D3拮抗剂(ab120567)
Key features and details
- Potent, highly selective D3 antagonist
- CAS Number: 1226917-67-4
- Soluble in water to 10 mM, in ethanol to 10 mM and in DMSO to 100 mM
- Form / State: Solid
- Source: Synthetic
概述
-
产品名称
SB-277011-A dihydrochloride，D3拮抗剂 -
描述
Potent，highly selective D3拮抗剂 -
生物学描述
Potent, highly selective D3 receptor antagonist (pKi = 7.95 at hD3 receptors). Exhibits over 100-fold selectivity over D2 receptors. Blood-brain barrier (BBB) permeable. Diminishes nicotine, cocaine and alcohol self-administration. Interferes with mechanisms of drug-taking and reinstatement of drug-taking behaviours.
-
CAS编号
1226917-67-4 -
化学结构
性能
-
化学名称
N-[trans-4-[2-(6-Cyano-3,4-dihydro-2(1H)-isoquinolinyl)ethyl]cyclohexyl]-4-quinolinecarboxamide dihydrochloride -
分子量
511.49 -
分子式
C28H30N4O.2HCl -
PubChem识别号
75358288 -
存放说明
Store at +4°C. Store under desiccating conditions. The product can be stored for up to 12 months. -
溶解度概述
Soluble in water to 10 mM, in ethanol to 10 mM and in DMSO to 100 mM -
处理
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.
Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.
-
SMILES
C1CC(CCC1CCN2CCC3=C(C2)C=CC(=C3)C#N)NC(=O)C4=CC=NC5=CC=CC=C45.Cl.Cl -
来源
Synthetic
-
研究领域
图片
-
Chemical Structure - SB-277011-A dihydrochloride, D3 antagonist (ab120567)2D chemical structure image of ab120567, SB-277011-A dihydrochloride, D3 antagonist
实验方案
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
文献 (1)
ab120567 被引用在 1 文献中.
- Rodgers HM et al. Dopamine D1 and D3 receptor modulators restore morphine analgesia and prevent opioid preference in a model of neuropathic pain. Neuroscience 406:376-388 (2019). PubMed: 30910641